AI For Pharma Growth

In this episode of AI For Pharma Growth, Dr. Andree Bates is joined by Navid Alipour, CEO of CureMetrix, which is a leading AI-powered medical imaging company that specialises in early detection of breast cancer and heart disease. The company has received two historic FDA clearances for its AI-powered breast cancer detection and breast arterial calcification detection products.   Navid & Andree di...

In this episode of AI For Pharma Growth, Dr. Andree Bates is joined by Julien Willard, a Partner and Life Science Lead at IBM.  Julien is focused on how AI is being used to tackle global health challenges, particularly in low and middle-income countries (LMICs).    Julien & Andree discuss the importance of accounting for local context when implementing tech into healthcare, overcoming limited data...

In this episode of AI For Pharma Growth, Dr. Andree Bates talks to Dr Andrew Rut, CEO of Metadvice, about how AI is at the forefront of improvements to the pharmaceutical industry.   Metadvice uses neural networks to enable clinicians to handle patients faster and with greater accuracy. It utilises both synthetic and real data to achieve an incredibly high level of accuracy whilst following all me...

In this episode of AI For Pharma Growth, Dr. Andree Bates explores the pivotal role of AI in boosting team productivity within pharmaceutical companies, alongside Tim Cakir, CEO of TaskDrive.   Tim's insights stem from his background as a growth consultant, driving TaskDrive's evolution towards AI-augmented virtual assistants and achieving remarkable efficiency gains.   Founded with a focus on tra...

In this episode, Dr. Andree Bates speaks with Jordan Miller, Founder of Satori, an open-source, decentralised AI prediction network. The project integrates AI and machine learning to enhance predictive capabilities.   Jordan has spent the last decade building a worldwide prediction AI network and the past two years bringing it to life.   His career as a lead developer, with a background in Busines...

In this episode, Dr. Andree Bates speaks with Professor Shafi Ahmed and discusses how innovation and disruptive thinking can transform healthcare, making it more accessible and affordable for everyone.   Professor Shafi Ahmed is a renowned surgeon and co-founder of Medical Realities, a company pioneering the use of virtual and augmented reality in medical education and training.   In this episode...

In this episode, Dr. Andree Bates speaks with Tristan Salomon, Founder and CEO of Axom, a company specialising in advanced AI solutions for the pharmaceutical industry.   Tristan Salomon has a rich background in developing and implementing AI technologies to enhance manufacturing processes. His expertise lies in creating innovative solutions that improve quality control and traceability, ensuring...

In this episode, Dr. Andree Bates speaks with Johannes Kraus, Co-Founder of YOUTH HealthTech.   As a former physical therapist Johannes experienced patients suffering and approaching him every day, barely able to treat their diseases without the ability to properly follow their prevention.   He founded YOUTH to prevent diseases by focusing on early detection, leveraging data from smartphones and u...

Today Dr Andree Bates chats with Dr Giulio Rognini, Head of Partnerships at Metaphysiks, about how Metaphysiks is revolutionising the world of haptic feedback.   Metaphysiks is leading the charge in blending human sensation with the digital realm through their innovative neuro-haptic technology. They’ve even developed the world’s first proprietary neuro-haptic skin – a true game-changer in immersi...

In this episode of AI For Pharma Growth, Dr. Andree Bates is joined by Abishek Jha, Co-Founder and CEO of Elucidata, which cleans and links biomedical data at scale. They advocate for a data-centric approach to AI, arguing that clean data is more valuable than copious data.   In this episode, you will learn: How Elucidata’s sources and processes data The problems they solve for biopharma companies...

In this episode of AI For Pharma Growth, Dr. Andree Bates is joined by Eric Doherty, who has worked in the pharmaceutical industry for 33 years and also in healthcare data AI for 4 years. He is the Former President of PERSOWN, Inc., a medical device company that is developing the next generation of instant Point-of-Care (POC) diagnostic testing, using electro-chemical biosensors.   They speak abou...

In this episode of AI For Pharma Growth, Dr. Andree Bates is joined by Philipp Lorenz, Chief Technology Officer of Basecamp Research.   Basecamp Research is a market leader in mapping biodiversity for AI-based design of biological systems. They match and refine novel proteins for your exact industrial or therapeutic and diagnostic applications.   In this episode you will learn: How Basecamp collec...

In this episode of AI For Pharma Growth, Dr. Andree Bates is joined by Matt Van Itallie, Founder and CEO of Sema.  Sema is a software company that is squarely focused on understanding and improving tech. They build tools that bring technologists and non-technologists together. They’ve successfully managed the risks of Gen AI whilst capturing the benefits in the software development life cycle. The...

In this episode of AI For Pharma Growth, Dr. Andree Bates is joined by Ben Weintraub, the President of InThought Research and Doug Foster, Creator of the inVision software. inThought Research is a leading pharmaceutical and life science consulting firm providing analytical, forecasting, and competitive intelligence services to support strategic and tactical decisions of biopharmaceutical and finan...

Today Dr Andree Bates talks to Patricia Gall, Founder and CEO of MindSpark 360, about the organisation's pivotal role in advancing mental health innovation.   MindSpark 360 operates as a structured programme, fostering open communication among all stakeholders in the mental health sector. Whether collaborating with corporations prioritising employee well-being or partnering with organisations driv...

In this episode of AI For Pharma Growth, Dr. Andree Bates is joined by Eunice Wu, Co-Founder and CEO of Asepha. Asepha helps Pharmacies to work efficiently and faster through specific and intelligent tests on their AI models. Eunice explains the potential of AI in revolutionising pharmacy operations and patient care, particularly through improved speed and accuracy in repetitive tasks.   Eunice po...

In this episode of AI For Pharma Growth, Dr Andree Bates is joined by haemato-oncologist Niamh Boyle, who works in the Health Economic Evaluation of Precision Medicine in Cancer research project, University of South Wales.   Andree and Niamh discuss the use of AI in research methodologies and processes related to precision oncology. They also talk about how Health Technology Appraisal (HTA) bodies...

In this episode of AI For Pharma Growth, Dr Andree Bates is joined by Liam Kaufman, Vice President of Cambridge Cognition.   Andree and Liam talk about the use of AI during Central Nervous System (CNS) clinical research trials. They delve into how brain health and neural pathways can be explored and analysed, solely with the use of modern scientific technology.   Cambridge Cognition’s work has bee...

In this episode of AI For Pharma Growth, Dr Andree Bates is joined by Patrick Henz, Head of Governance, Risk and Compliance at a leading engineering and plant construction company.   In this episode, Andree and Patrick discuss the relevance and implementation of AI in compliance and risk. They explore the ethics and complexities of this practice by individuals and big corporations, as well as the...

In this episode of AI For Pharma Growth, Dr Andree Bates is joined by Dr Michelle Oyen, Associate Professor of Biomedical Engineering at Washington University in St. Louis.    Michelle discusses the use and importance of AI in the field of maternal and fetal health. When an unexpected source changes Michelle’s career trajectory, she used her engineering background to research computational models...

In this episode of AI For Pharma Growth, Dr Andree Bates is joined by Hon Weng Chong, M.D., the founder of Cortical Labs. They discuss the inception of Cortical Labs and how the company is responsible for the creation of DishBrain, a powerful computational neuron system using human brain cells. Eventually, this cellular neuron system became so adaptive and responsive, it learned how to play the cl...

In this episode of AI For Pharma Growth, Dr Andree Bates is joined by Patrick Glinski and Ryan Brotman, the co-founders of Composehealth.ai. They discuss the use of artificial intelligence to automate the creation of an accurate content compliance review process, ready for use by individuals and businesses.   Compose Health is an AI platform that gives its users a precise method of drafting and ge...

In this episode of AI For Pharma Growth, Dr Andree Bates is joined by Ari Caroline, CEO of Weave Bio, to discuss how the company is using artificial intelligence to streamline the IND application process for new therapeutics.   Weave Bio has developed an AI-powered platform that aims to cut the typical four month IND drafting time in half by automatically generating initial drafts of IND applicati...

In this episode of AI For Pharma Growth, Dr Andree Bates speaks with Manny Nsien, MHA the CEO of Ripple Ranch, an addiction treatment centre located in Texas.   They talk about how artificial intelligence can be leveraged to more precisely diagnose those suffering from addiction earlier by analysing various streams of patient data, including information from medical records, wearable devices, gene...

In this episode of AI For Pharma Growth, Dr Andree Bates is joined by Emanuel Rose to talk about Authentic Marketing in the Age of AI.   You will learn how 51% of marketers are now using AI and various ways it's being used, including for copywriting, creative support, and data analysis. Emanuel discusses using AI in marketing while maintaining authenticity and emphasising brand voice, content cale...